What Is a Cord Blood Registry and How Does It Work?
When you're expecting a baby, you may come across information about preserving your newborn's cord blood—the blood remaining in the umbilical cord and placenta after delivery. A cord blood registry is the organization or facility that collects, tests, processes, and stores this blood for potential future medical use. Understanding what a registry is, how it operates, and what to evaluate will help you make an informed decision about whether cord blood banking makes sense for your family.
What Cord Blood Is and Why It Matters 🩸
Cord blood contains hematopoietic stem cells—primitive cells capable of developing into blood and immune system cells. These cells have been used in transplant procedures to treat certain blood disorders, cancers, and immune deficiencies. The potential for future therapies is why some families choose to preserve cord blood at birth, when collection is non-invasive and the cells are viable.
However, the current established medical uses remain limited. Cord blood transplants are an approved treatment for conditions like leukemia, lymphoma, and sickle cell disease in specific circumstances—typically when a matched donor is needed and umbilical cord blood offers a viable alternative to bone marrow. The number of conditions with established treatments using cord blood is much smaller than the broader range of conditions sometimes promoted in marketing materials.
The Two Types of Cord Blood Registries
Cord blood registries fall into two distinct categories, each serving different purposes and operating under different models.
Public Cord Blood Banks
Public registries collect and store cord blood altruistically. Families donate cord blood at no cost, and the blood enters an inventory available to anyone in need of a transplant—patients of any age or background. These registries are typically nonprofit organizations, hospital networks, or research institutions.
Public banks do not guarantee that a family's own child will have access to their donated cord blood. Once donated, the sample becomes part of the public inventory. These banks are regulated by the FDA and must meet strict standards for collection, processing, testing, and storage.
Public cord blood banking removes the financial barrier and supports research and treatment access for patients without private resources. However, families receive no exclusive claim to the stored blood.
Private Cord Blood Banks
Private registries store cord blood exclusively for the family that provides it. Families pay an upfront collection and processing fee (amounts vary widely by provider) plus annual storage fees. The stored blood is reserved for potential use by the child, siblings, or sometimes parents—depending on the bank's policies and the family's agreement.
Private banks are for-profit or nonprofit businesses. They operate similarly to public banks in terms of collection and storage standards, but the ownership model and access rights differ fundamentally.
The premise of private banking rests on the possibility that a child might develop a condition treatable with their own cord blood in the future. However, it's important to note that most children will never use their stored cord blood. Private banking is also a financial commitment—families need to be prepared for storage fees spanning decades if they want to maintain the deposit.
How a Cord Blood Registry Operates
Understanding the workflow helps clarify what a registry actually does.
Collection happens immediately after delivery—usually within 10 to 15 minutes—before the umbilical cord is clamped and cut. A healthcare provider draws blood from the cord into a sterile collection bag containing anticoagulant. The process is painless and poses no risk to mother or baby.
Transportation involves getting the sample to the registry's laboratory, typically within 24 to 48 hours, to maintain cell viability.
Testing screens for infectious diseases (HIV, hepatitis B and C, syphilis, and others), bacterial and fungal contamination, and cell viability. The registry also performs HLA typing—genetic testing that determines tissue compatibility, critical for transplant matching.
Processing may involve concentration and removal of red blood cells and plasma to reduce the final volume, making long-term storage more efficient. Some registries cryopreserve samples using dimethyl sulfoxide (DMSO), a cryoprotectant, before freezing at extremely low temperatures.
Storage occurs in liquid nitrogen tanks or other specialized freezing systems, where samples can theoretically remain viable for decades. Registries monitor temperature, power, and system integrity continuously.
Tracking and inventory management keep detailed records of each sample's location, viability status, and test results, enabling rapid retrieval if a transplant is needed.
Key Factors That Shape Registry Choices
Several variables determine whether a particular cord blood registry is a good fit for a family's situation.
Regulatory oversight and accreditation affect quality and reliability. In the United States, the FDA regulates cord blood banks. Many registries pursue accreditation from organizations like AABB (formerly the American Association of Blood Banks) or FACT-NetCord, which impose additional standards. Accreditation is a marker of accountability, though lack of accreditation doesn't automatically mean poor service.
Processing methods differ among registries. Some use volume reduction (concentrating cells), while others store the full sample. These technical choices affect cell recovery rates and long-term viability, though outcomes vary.
Storage infrastructure and redundancy matter for long-term reliability. Registries with backup power systems, multiple storage facilities, and monitoring technology reduce risk of sample loss due to equipment failure.
Transparency about outcomes is worth evaluating. Reputable registries provide realistic information about current therapeutic uses, acknowledge the speculative nature of future applications, and avoid overstating the likelihood that a child will use their cord blood.
Financial stability of private banks is relevant if you're committing to decades of storage fees. A registry with unclear ownership, frequent staff turnover, or uncertain funding poses risks.
Accessibility for transplant matching matters if storage is intended as potential insurance. Public banks participate in national and international registries that facilitate matching. Private banks may have more limited matching networks.
Questions to Evaluate Before Choosing a Registry
If you're considering cord blood banking, these distinctions will help you assess what matters to your family:
- Are you storing for exclusive family use (private) or contributing to a public inventory available to anyone?
- What are the upfront and ongoing costs, and for how long are you prepared to pay storage fees?
- What medical conditions does the registry acknowledge as having established treatments with cord blood? How does this compare to marketing claims about future applications?
- Is the registry accredited by recognized organizations, and what regulatory oversight applies?
- If the registry is private, what is its financial track record and ownership stability?
- What testing and processing standards does the registry follow, and are these transparent?
- If transplant is needed, how will matching and retrieval be handled?
The Reality of Cord Blood Use Today
The majority of cord blood stored privately never gets used. The conditions currently treatable with cord blood transplants are relatively rare. Additionally, a child's own cord blood cannot be used to treat genetic blood disorders or certain cancers—conditions the child was born with or inherited. This limits the therapeutic window for autologous (self) use.
Over time, cell viability may decline, though well-stored samples can remain viable for extended periods. Registries vary in how they communicate viability rates or what happens to non-viable samples.
The landscape of potential future therapies—regenerative medicine, expanded immune treatments—is evolving. Some families view cord blood banking as a hedge against medical uncertainty. Others consider the established current uses and low probability of personal use to mean private banking isn't a worthwhile expense.
Neither choice is universal; it depends on how a family weighs financial investment, medical reality, and personal values around health preparedness.
Key Takeaways
A cord blood registry is a specialized facility managing the collection, testing, processing, and storage of umbilical cord blood. Public registries serve patients in need through altruistic donation; private registries preserve blood exclusively for the donor family. Both types operate under regulatory oversight, but differ fundamentally in access, cost, and ownership. Your decision about whether to bank cord blood—and with which type of registry—depends on your values regarding medical preparedness, financial commitment, and how you weigh established current uses against speculative future therapies.